Prostate-specific antigen response in black and white patients treated with abiraterone acetate for metastatic castrate–resistant prostate cancer-Reference-Cited by-同舟云学术

Prostate-specific antigen response in black and white patients treated with abiraterone acetate for metastatic castrate–resistant prostate cancer

Published:2017-06 Issue:6 Volume:35 Page:418-424
ISSN:1078-1439
Container-title:Urologic Oncology: Seminars and Original Investigations
language:en
Short-container-title:Urologic Oncology: Seminars and Original Investigations

Author:

Ramalingam Sundhar,Humeniuk Michael S.,Hu Rachel,Rasmussen Julia,Healy Patrick,Wu Yuan,Harrison Michael R.,Armstrong Andrew J.,George Daniel J.,Zhang Tian

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference18 articles.

1. Cancer statistics, 2013;Siegel;CA Cancer J Clin,2013

2. Molecular mechanisms involving prostate cancer racial disparity;Hatcher;Am J Transl Res,2009

3. Genetic variation at five trimeric and tetrameric tandem repeat loci in four human population groups;Edwards;Genomics,1992

4. Androgen receptor-target genes in African American prostate cancer disparities;Wang;Prostate Cancer,2013

5. Abiraterone and increased survival in metastatic prostate cancer;de Bono;N Engl J Med,2011

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of Survival Outcomes Among Black and White Patients with Metastatic Castration-resistant Prostate Cancer: A Systematic Review and Meta-analysis;European Urology Open Science;2024-03

2. Disparities With Systemic Therapies for Black Men Having Advanced Prostate Cancer: Where Do We Stand?;Journal of Clinical Oncology;2024-01-10

3. Advancing Equity in Cancer Research: Opportunities for Sponsors, Institutions, and Investigators;North Carolina Medical Journal;2024-01-09

4. The impact of race on survival in metastatic prostate cancer: a systematic literature review;Prostate Cancer and Prostatic Diseases;2023-08-17

5. Prostate-specific antigen response and clinical progression-free survival in Black and White men with chemotherapy-naïve metastatic castration-resistant prostate cancer treated with enzalutamide in a real-world setting;Prostate Cancer and Prostatic Diseases;2022-12-14